CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 301 enrolled
Drug / intervention
estradiol tablet +1 moredrug
Likely dose
estradiol tablet 2 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01367912
NCT01367912N/ACompleted
CompareCT.gov

Timing of Estrogen Support During the Luteal Phase of IVF / Intracytoplasmic Sperm Injection Cycle: a Randomized Controlled Trial

Zekai Tahir Burak Women's Health Research and Education Hospital·interventional·Posted Jun 7, 2011·Updated Jun 7, 2011

In Brief

A clinical study evaluating estradiol tablet for Infertility. Completed, enrolled 301 participants across 1 site.

Detailed Summary

To test the hypothesis that adding estradiol (E2) to progesterone supplementation later in the luteal phase of in vitro fertilization (IVF)/intracytoplasmic sperm injection (ICSI) cycles, rather than earlier in the luteal phase, improves clinical pregnancy rates (PRs).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsInfertility
CountriesTurkey (Türkiye)
Collaborators--

Timeline

N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJun 7, 2011
Enrollment StartFeb 1, 2008
Primary CompletionNov 1, 2008
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 15.1 years ago

Interventions

estradiol tabletdrug

received 2 mg estradiol tablets orally two times daily beginning from the first day after hCG injection, in addition to vaginal progesterone gel

estradiol tabletdrug

received 2 mg estradiol tablets orally two times daily beginning from the fifth day after hCG injection, in addition to vaginal progesterone gel.